LeafCann is one of Western Australia’s leading cannabis companies. With a strong focus on people, planet and profit, they produce potent organic medical cannabis for distribution in Australia.
Partnering with universities and medical facilities, they are following a ‘Seed to Sale’ model to supply organic CBD and THC oil products nationally. Supply chains and export agreements are the foundation of LeafCann, and their vision is to provide affordable and high-quality cannabis treatment to patients.
LeafCann is positioned between Canberra, Victoria and Western Australia. Their strengths lay within relationship management and public relations that allows them to build partnerships with well-known universities and medical bodies effectively.
Elisabetta Faenza, the CEO, is co-founder of LeafCann and has deep experience with public relations and relationship management. She leads as a professional spokesperson that can open up new doors and opportunities that would be otherwise left closed for most other cannabis companies.
They have showcased various cannabis products including:
Oral administration of liquids (oils, tinctures and beverages)
Oral administration of solids (capsules/tablets, edible products, cannabis powder and oil)
Topical administration straight on the skin (creams, balms, ointments, transdermal patches etc.)
Suppositories (tablets or capsules)
Inhalation (smoking and vaporising dried marijuana buds)
Insufflation (nasal sprays)
What’s new with LeafCann Group
February 11, 2020:Food and Drink Business covers an article around “Water-soluble CBD” and references LeafCann as a key player in providing Australian grown medicines in more forms than just dry flower and oil.
February 5, 2020: South Australia’ Department for Trade and Investment announces the Major Project Status for Leaf Cann.
February 3, 2020: Updates their website to announce the Major Project Status that includes:
$350 million investment
support from national, state and local governments
projection of employment for over 1400 jobs
additional 850 jobs to assist in the development of their facility
Opening trade offices in China, Japan, Houston, Dubai and Malaysia
January 16, 2020: The Medicinal Cannabis Industry Australia (MCIA) hosts a major international event that includes CannGroup, LeafCann and MedReleaf.
Disclaimer: Cannabis Place may contain information regarding cannabis & other drugs; it is designed for 18+ audiences in regions where cannabis has been decriminalised. This topic may represent illegal activity in certain regions. We do not encourage illegal activity. We understand that readers in locations where cannabis has been legalised may read these articles. Medical Cannabis in Australia is regulated by the Therapeutic Goods Administration and details about Cannabis as a scheduled drug can be found on their website. Please consult with your doctor to find out if Cannabis is right for you. Click here for our full disclaimer
Tasmanian Botanics is a family-owned and runs cannabis cultivation, production and research company. Their focus is to utilise Tasmania's clean environment and their modern cultivation facility to produce medical-grade cannabis for Australian and international distribution.